Seek Returns logo

IQV vs. PHG: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at IQV and PHG, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

IQV is a standard domestic stock, while PHG trades as New York Registered Shares, providing U.S. investors with a way to invest in the foreign-based company.

SymbolIQVPHG
Company NameIQVIA Holdings Inc.Koninklijke Philips N.V.
CountryUnited StatesNetherlands
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesHealth Care Equipment & Supplies
Market Capitalization34.64 billion USD26.27 billion USD
ExchangeNYSENYSE
Listing DateMay 9, 2013March 17, 1980
Security TypeCommon StockNY Reg Shrs

Historical Performance

This chart compares the performance of IQV and PHG by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

IQV vs. PHG: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolIQVPHG
5-Day Price Return4.80%-1.58%
13-Week Price Return20.53%10.82%
26-Week Price Return5.51%-2.91%
52-Week Price Return-19.10%-21.55%
Month-to-Date Return-0.46%-2.17%
Year-to-Date Return-3.34%-5.57%
10-Day Avg. Volume1.15M1.37M
3-Month Avg. Volume1.84M1.61M
3-Month Volatility46.55%26.07%
Beta1.341.07

Profitability

Return on Equity (TTM)

IQV

19.96%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.51%
Median
6.47%
Q1
3.86%
Min
-6.95%

In the upper quartile for the Life Sciences Tools & Services industry, IQV’s Return on Equity of 19.96% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

PHG

-0.18%

Health Care Equipment & Supplies Industry

Max
29.93%
Q3
16.99%
Median
9.28%
Q1
5.10%
Min
-12.52%

PHG has a negative Return on Equity of -0.18%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

IQV vs. PHG: A comparison of their Return on Equity (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Net Profit Margin (TTM)

IQV

7.88%

Life Sciences Tools & Services Industry

Max
32.18%
Q3
18.30%
Median
10.19%
Q1
4.20%
Min
-2.05%

IQV’s Net Profit Margin of 7.88% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

PHG

0.90%

Health Care Equipment & Supplies Industry

Max
24.41%
Q3
13.71%
Median
10.08%
Q1
5.96%
Min
-5.58%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Net Profit Margin of 0.90% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

IQV vs. PHG: A comparison of their Net Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Operating Profit Margin (TTM)

IQV

13.85%

Life Sciences Tools & Services Industry

Max
38.39%
Q3
21.40%
Median
13.57%
Q1
8.38%
Min
-3.51%

IQV’s Operating Profit Margin of 13.85% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

PHG

6.11%

Health Care Equipment & Supplies Industry

Max
31.09%
Q3
18.11%
Median
15.07%
Q1
8.48%
Min
-0.28%

PHG’s Operating Profit Margin of 6.11% is in the lower quartile for the Health Care Equipment & Supplies industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

IQV vs. PHG: A comparison of their Operating Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Profitability at a Glance

SymbolIQVPHG
Return on Equity (TTM)19.96%-0.18%
Return on Assets (TTM)4.50%-0.08%
Net Profit Margin (TTM)7.88%0.90%
Operating Profit Margin (TTM)13.85%6.11%
Gross Profit Margin (TTM)34.25%43.85%

Financial Strength

Current Ratio (MRQ)

IQV

0.84

Life Sciences Tools & Services Industry

Max
3.46
Q3
2.78
Median
1.91
Q1
1.53
Min
0.43

IQV’s Current Ratio of 0.84 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

PHG

1.26

Health Care Equipment & Supplies Industry

Max
5.19
Q3
3.00
Median
2.13
Q1
1.44
Min
0.86

PHG’s Current Ratio of 1.26 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

IQV vs. PHG: A comparison of their Current Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Debt-to-Equity Ratio (MRQ)

IQV

2.68

Life Sciences Tools & Services Industry

Max
1.35
Q3
0.74
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 2.68, IQV operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

PHG

0.81

Health Care Equipment & Supplies Industry

Max
1.61
Q3
0.76
Median
0.45
Q1
0.14
Min
0.00

PHG’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.81. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

IQV vs. PHG: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Interest Coverage Ratio (TTM)

IQV

3.68

Life Sciences Tools & Services Industry

Max
45.00
Q3
27.84
Median
7.16
Q1
2.12
Min
-14.08

IQV’s Interest Coverage Ratio of 3.68 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

PHG

1.41

Health Care Equipment & Supplies Industry

Max
56.35
Q3
25.56
Median
9.60
Q1
3.78
Min
-26.49

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Interest Coverage Ratio of 1.41 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

IQV vs. PHG: A comparison of their Interest Coverage Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Financial Strength at a Glance

SymbolIQVPHG
Current Ratio (MRQ)0.841.26
Quick Ratio (MRQ)0.810.81
Debt-to-Equity Ratio (MRQ)2.680.81
Interest Coverage Ratio (TTM)3.681.41

Growth

Revenue Growth

IQV vs. PHG: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

IQV vs. PHG: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

IQV

0.00%

Life Sciences Tools & Services Industry

Max
1.41%
Q3
0.65%
Median
0.35%
Q1
0.00%
Min
0.00%

IQV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

PHG

0.00%

Health Care Equipment & Supplies Industry

Max
4.15%
Q3
1.76%
Median
0.79%
Q1
0.00%
Min
0.00%

PHG’s Dividend Yield of 0.00% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.

IQV vs. PHG: A comparison of their Dividend Yield (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend Payout Ratio (TTM)

IQV

0.00%

Life Sciences Tools & Services Industry

Max
113.14%
Q3
61.34%
Median
17.74%
Q1
0.00%
Min
0.00%

IQV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

PHG

0.42%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
66.60%
Median
27.49%
Q1
0.00%
Min
0.00%

PHG’s Dividend Payout Ratio of 0.42% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

IQV vs. PHG: A comparison of their Dividend Payout Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend at a Glance

SymbolIQVPHG
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.42%

Valuation

Price-to-Earnings Ratio (TTM)

IQV

27.58

Life Sciences Tools & Services Industry

Max
75.35
Q3
51.00
Median
32.93
Q1
25.27
Min
1.43

IQV’s P/E Ratio of 27.58 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

PHG

136.03

Health Care Equipment & Supplies Industry

Max
67.29
Q3
47.01
Median
30.94
Q1
23.91
Min
10.79

At 136.03, PHG’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Health Care Equipment & Supplies industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

IQV vs. PHG: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Sales Ratio (TTM)

IQV

2.17

Life Sciences Tools & Services Industry

Max
10.49
Q3
6.43
Median
4.66
Q1
2.88
Min
1.08

In the lower quartile for the Life Sciences Tools & Services industry, IQV’s P/S Ratio of 2.17 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

PHG

1.23

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.86
Q1
2.07
Min
0.74

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s P/S Ratio of 1.23 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

IQV vs. PHG: A comparison of their Price-to-Sales Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Book Ratio (MRQ)

IQV

4.72

Life Sciences Tools & Services Industry

Max
6.69
Q3
5.00
Median
3.46
Q1
2.38
Min
0.93

IQV’s P/B Ratio of 4.72 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

PHG

1.89

Health Care Equipment & Supplies Industry

Max
10.85
Q3
6.56
Median
3.53
Q1
2.36
Min
0.71

PHG’s P/B Ratio of 1.89 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

IQV vs. PHG: A comparison of their Price-to-Book Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Valuation at a Glance

SymbolIQVPHG
Price-to-Earnings Ratio (TTM)27.58136.03
Price-to-Sales Ratio (TTM)2.171.23
Price-to-Book Ratio (MRQ)4.721.89
Price-to-Free Cash Flow Ratio (TTM)16.9714.24